These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 8466400

  • 1. Matrix effects in therapeutic drug monitoring surveys. Proposed protocol to identify error components and quality improvement opportunities.
    Witte DL.
    Arch Pathol Lab Med; 1993 Apr; 117(4):373-80. PubMed ID: 8466400
    [Abstract] [Full Text] [Related]

  • 2. The accuracy of laboratory measurements in clinical chemistry: a study of 11 routine chemistry analytes in the College of American Pathologists Chemistry Survey with fresh frozen serum, definitive methods, and reference methods.
    Ross JW, Miller WG, Myers GL, Praestgaard J.
    Arch Pathol Lab Med; 1998 Jul; 122(7):587-608. PubMed ID: 9674541
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Matrix effects and the accuracy of cholesterol analysis.
    Ross JW, Myers GL, Gilmore BF, Cooper GR, Naito HR, Eckfeldt J.
    Arch Pathol Lab Med; 1993 Apr; 117(4):393-400. PubMed ID: 8466403
    [Abstract] [Full Text] [Related]

  • 5. Matrix effects on proficiency testing materials. Impact on accuracy of cholesterol measurement in laboratories in the nation's largest hospital system.
    Naito HK, Kwak YS, Hartfiel JL, Park JK, Travers EM, Myers GL, Ross JW, Eckfeldt JH, Hartmann AE.
    Arch Pathol Lab Med; 1993 Apr; 117(4):345-51. PubMed ID: 8466396
    [Abstract] [Full Text] [Related]

  • 6. Achieving accuracy for routine clinical chemistry methods by using patient specimen correlations to assign calibrator values. A means of managing matrix effects.
    Lasky FD.
    Arch Pathol Lab Med; 1993 Apr; 117(4):412-9. PubMed ID: 8466405
    [Abstract] [Full Text] [Related]

  • 7. Statistical power in the detection of matrix effects.
    Long T.
    Arch Pathol Lab Med; 1993 Apr; 117(4):387-92. PubMed ID: 8466402
    [Abstract] [Full Text] [Related]

  • 8. Matrix effects in blood gas proficiency testing.
    Burnett RW.
    Arch Pathol Lab Med; 1993 Apr; 117(4):365-8. PubMed ID: 8466398
    [Abstract] [Full Text] [Related]

  • 9. Matrix effects and accuracy assessment. Identifying matrix-sensitive methods from real-time proficiency testing data.
    Lawson NS, Williams TL, Long T.
    Arch Pathol Lab Med; 1993 Apr; 117(4):401-11. PubMed ID: 8466404
    [Abstract] [Full Text] [Related]

  • 10. A manufacturer's approach to development of matrix robust methods.
    Rautela GS.
    Arch Pathol Lab Med; 1993 Jul; 117(7):691-5. PubMed ID: 8323429
    [Abstract] [Full Text] [Related]

  • 11. Control serum for therapeutic drug monitoring.
    Schneiderka P, Hostlovská M, Loub L.
    Sb Lek; 1994 Jul; 95(4):373-81. PubMed ID: 8867709
    [Abstract] [Full Text] [Related]

  • 12. External quality assessment of serum hormone determinations in the Nordic countries.
    Ruokonen A, Leskinen E, Nyberg A, Vihko R.
    Scand J Clin Lab Invest Suppl; 1984 Jul; 172():125-34. PubMed ID: 6599513
    [Abstract] [Full Text] [Related]

  • 13. The detection of problem analytes in a single proficiency test challenge in the absence of the Health Care Financing Administration rule violations.
    Cembrowski GS, Hackney JR, Carey N.
    Arch Pathol Lab Med; 1993 Apr; 117(4):437-43. PubMed ID: 8466413
    [Abstract] [Full Text] [Related]

  • 14. The stability of survey-assigned assay values when surveyed control materials are used in a daily interlaboratory quality control program. The College of American Pathologists Chemistry Survey--Quality Assurance Service shared pool experience.
    Lawson PL, Lawson NS, Ross JW.
    Arch Pathol Lab Med; 1995 Apr; 119(4):312-33. PubMed ID: 7726725
    [Abstract] [Full Text] [Related]

  • 15. Estimating the biases of the Korean national cholesterol proficiency test.
    Park J, Chun S, Kim JQ, Song J, Kim JJ, Min WK.
    Ann Clin Lab Sci; 2010 Apr; 40(1):53-60. PubMed ID: 20124331
    [Abstract] [Full Text] [Related]

  • 16. Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.
    Holland DT, DiFrancesco R, Connor JD, Morse GD.
    Ther Drug Monit; 2006 Jun; 28(3):367-74. PubMed ID: 16778721
    [Abstract] [Full Text] [Related]

  • 17. Appropriateness of therapeutic drug monitoring for lithium.
    Ratanajamit C, Soorapan S, Doang-ngern T, Waenwaisart W, Suwanchavalit L, Suwansiri S, Jantasaro S, Yanate I.
    J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880
    [Abstract] [Full Text] [Related]

  • 18. Preliminary observations on the Quality Assurance Service Therapeutic Drug Monitoring Program.
    Lohff MR.
    Am J Clin Pathol; 1980 Oct; 74(4 Suppl):542-5. PubMed ID: 7435445
    [Abstract] [Full Text] [Related]

  • 19. The effects of modifying proficiency testing materials on thyroid function test results. A College of American Pathologists Ligand Assay Survey Study.
    Steele BW, Witte DL, Whitley RJ, Klee GG, Chan DW.
    Arch Pathol Lab Med; 1997 Dec; 121(12):1241-6. PubMed ID: 9431312
    [Abstract] [Full Text] [Related]

  • 20. Recommendations for the selection and use of protocols for assignment of values to reference materials.
    Johnson AM, Sampson EJ, Blirup-Jensen S, Svendsen PJ.
    Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):279-85. PubMed ID: 8721419
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.